Aripiprazol: omais novo antipsicótico de nova geração
Fanti, Luciana M; Costa, Anna Maria N.
Psiquiatr. biol
; 11(1): 15-21, mar. 2003. ilus
Artículo en Portugués | LILACS | ID: lil-359709
Documentos relacionados
D<sub>2/3</sub> Agonist during Learning Potentiates Cued Risky Choice.
Dopamine system involvement in impulse control.
Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein.
Enhanced D2 Agonism Induces Conditioned Appetitive Sexual Responses Toward Non-reproductive Conspecifics.
Othello syndrome in Parkinson's disease: A diagnostic emergency of an underestimated condition.
Reply to: Safety of dopamine agonists for treating restless legs syndrome.
Safety of dopamine agonists for treating restless legs syndrome.
Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study.
Effects of dopamine modulation on chronic stress-induced deficits in reward learning.
Enhanced Taste Recognition Following Subacute Treatment With The Dopamine D2/D3 Receptor Agonist Pramipexole in Healthy Volunteers.